Previous Article | Next Article ![]()
Journal of Virology, February 2003, p. 1757-1763, Vol. 77, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.3.1757-1763.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Seccion Virologia, Facultad de Ciencias, Montevideo 11400, Uruguay,1 UMR CNRS-INRA Virologie Moléculaire et Structurale, 91198 Gif-sur-Yvette Cedex,2 INSERM U 538, Université Pierre et Marie Curie, 75012 Paris, France3
Received 18 July 2002/ Accepted 28 October 2002
|
|
|---|
|
|
|---|
Although several reports have described the characterization of rotavirus replication intermediates (RI), molecular details of the replication mechanisms remain unclear (12). Structural proteins VP1 and VP2 are essential components of the in vitro replicase activity (33). Two nonstructural proteins, NSP2 and NSP5, are associated with the RI in vivo, suggesting that they could participate in the early events of RNA replication (3, 26). In infected cells, these structural and nonstructural proteins have been shown to accumulate in large definite structures referred to as viroplasms. NSP2 has helix-destabilizing and nucleoside triphosphatase activity, suggesting a possible role in unwinding and packaging of the viral RNA (17, 29, 30). NSP5 is an O-glycosylated phosphoprotein that self-assembles into dimers and has nonspecific RNA-binding protein activity (15, 31). The protein also has an autokinase activity (5). NSP5 is present in infected cells and in the form of several phosphorylated isomers with apparent molecular masses ranging from 28 to 34 kDa. (2, 27). NSP5 can be chemically cross-linked in living cells with a complex made up of VP1 and NSP2 (1). In previous work NSP2 has been found associated with VP1 (19). The interaction of NSP5 with NSP2 was demonstrated in yeast by two-hybrid assays and was confirmed in virus-infected cells (27). Coexpression of NSP2 and NSP5 in uninfected cells generates viroplasm-like structures and up-regulates hyperphosphorylation of NSP5 (1, 11).
To better understand RNA packaging and replication, we have investigated the role of NSP5 in this process and its interaction with rotavirus structural proteins. We have shown that NSP5 interacts with VP2 in rotavirus-infected MA104 epithelial cells. This result was confirmed in reconstituted systems based on recombinant proteins expressed in baculovirus and bacterial systems. This interaction may be relevant to the function of NSP5 in replication complexes. It also suggests that, by binding to cores in the infected cell, NSP5 may block or delay outer capsid assembly and make it possible for these particles to continue replicase activity.
|
|
|---|
92VP2) (32), green fluorescent protein (GFP) fused to VP2 (BacGFP-
92VP2) (7), VP3 (BacRF3) (A. Charpilienne et al., unpublished data), VP6 (BacRF6) (22), and NSP5 (BacNSP5RF) (27). NSP5 fused to the carboxyl terminus of glutathione S-transferase (GST) was expressed in Escherichia coli BL21/DE3 transformed with recombinant plasmid pET41a+RF11.
Purification of rotavirus double-layered VLP.
Double-layered virus-like particles (VLP) composed of VP1, VP2, VP3 and VP6 (VLP1/2/3/6); of VP2 and VP6 (VLP2/6); of
92VP2 and VP6 (VLP2
92/6); and of VP2 fused to GFP and VP6 (VLP2GFP/6) were produced and purified as described previously (22). Briefly, Sf9 cells were collected at 7 days postinfection and treated with Freon 113. Cell extract was then mixed with CsCl, adjusted to obtain a refraction index of 1.360, and centrifuged for 16 h at 35,000 rpm in a Beckman SW55 rotor.
Expression of recombinant NSP5. NSP5 was expressed in Sf9 cells infected with BacNSP5RF and collected at 72 h postinfection. Cells (4 x 106) were swollen in 1 ml of hypotonic buffer (HB) (3 mM HEPES [pH 8], 3 mM NaCl, 0.5 mM MgCl2, 0.5 µg of leupeptin per ml, 2 µg of aprotinin per ml) and lysed with a Dounce homogenizer. Extracts were clarified by centrifugation at 5,000 x g for 15 min.
BL21pET41RF11 bacteria were grown at 37°C in Luria-Bertani medium to an optical density at 600 nm of 0.2 and then induced by addition of 5 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) and incubated overnight at 28°C. Cells were collected, treated with 1 mg of lysozyme per ml, and lysed by two rounds of sonication in phosphate-buffered saline containing 10 mM dithiothreitol, 1% Triton X-100, and 1% Tween 20. The lysate was clarified at 14,000 x g for 15 min, and the supernatant was incubated with glutathione-agarose beads overnight at 4°C. The beads were washed with phosphate-buffered saline, and proteins bound to glutathione-agarose were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie blue staining.
Coimmunoprecipitation and immunostaining. Rotavirus-infected MA104 cells (3 x 106) were collected at 5 h postinfection and lysed in 0.5 ml of 50 mM Tris-HCl (pH 8)-125 mM NaCl-30 mM KCl-0.1% Triton X-100-0.05% SDS-20 mM EDTA-2 µg of aprotinin/ml (IP buffer). Cell debris was pelleted by centrifugation at 100,000 x g for 15 min. Monoclonal antibody (MAb) 158G37 directed against NSP5 (27) (1 µl of ascitic fluid) was added to 300 µl of cell lysate supernatant and incubated overnight at 4°C. Alternatively, Sf9 cell lysate supernatant (150 µl) prepared as described above from cells infected with various recombinant baculoviruses were incubated with MAb 158G37. Complexes were precipitated with protein A bound to Sepharose 4B and washed with IP buffer or HB depending on whether they were obtained from MA104 or Sf9 cells, respectively.
Immunoprecipitated proteins were immunodetected after SDS-PAGE analysis and blotting on polyvinyl difluoride membranes by transverse electrophoresis in 10 mM 3-(cyclohexylamino)-1-propanesulfonic acid (CAPS) buffer, pH 11. MAbs 164E22 (22) and RV138 (20) were used for immunodetection of VP2 and VP6, respectively.
EM. Specimens for electron microscopy (EM) were prepared from CsCl gradient fractions containing VLP after desalting by passage through Sephadex G25 spun columns. Samples were applied to air-glow discharged carbon coated grids, blotted immediately with filter paper, and negatively stained with 2% uranyl acetate solution. Thin sections were prepared as described previously (8) from Sf9 cells infected with recombinant baculoviruses allowing the expression of one or several rotaviral proteins and fixed at 72 h postinfection. Grids were examined in a Philips CM12 electron microscope operated at 80 kV.
Viral particles binding to recombinant NSP5. Double-layered particles (DLP) and viral cores were purified as previously described (4). Glutathione-agarose beads loaded with recombinant GST-NSP5 were incubated overnight with 80 µg of CsCl gradient-purified VLP, DLP, or cores in a volume of 500 µl of 50 mM KCl-5 mM MgCl2-20 mM HEPES (pH 7)-0.5% Triton X-100 at 4°C. The beads were washed with the same buffer, and protein complexes were analyzed by SDS-PAGE, Coomassie blue stained, and further identified by immunostaining as described above.
Alternatively, 100 µl of NSP5-containing lysates prepared from BacNSP5RF-infected Sf9 cells as described above were mixed with 80 µg of CsCl-purified rotavirus particles (VLP2/6, VLP2GFP/6, VLP2
92/6, VLP1/2/3/6, and DLP), resuspended in HB, and incubated for 1 h on ice. Samples were layered onto a 4.5-ml CsCl density gradient and spun in a Beckman ultracentrifuge for 16 h at 35,000 rpm at 4°C in a SW55 rotor. As control, lysate prepared from Sf9 cells infected with a recombinant baculovirus allowing the expression of NSP2 was used under the same conditions.
|
|
|---|
![]() View larger version (75K): [in a new window] |
FIG. 1. Coimmunoprecipitation of VP2 with NSP5 in infected cells. MA104 cells infected with the RF strain of rotavirus (lanes RF) or mock infected (lanes M) were immunoprecipitated (IP) with an anti-NSP5 MAb, 158G37. VP2 and VP6 were immunodetected by Western blotting with anti-VP2 MAb 164E22 (left panel) or anti-VP6 MAb 138 (right panel), respectively. Sizes of molecular weight markers are indicated on the left in thousands. H and L, heavy and light chains of immunoglobulins, respectively.
|
92VP2 was substituted for wild-type VP2, indicating that the interaction between the two proteins is not mediated by the amino end of VP2 (not shown).
![]() View larger version (65K): [in a new window] |
FIG. 2. Coimmunoprecipitation of VP2 with NSP5 in baculovirus-infected cells. Sf9 cells infected with various recombinant baculoviruses were immunoprecipitated with an anti-NSP5 MAb (158G37), and VP2 present in complexes was detected with an anti-VP2 MAb (164E22) by Western blotting.
|
NSP5 modifies the subcellular distribution of VP2.
In rotavirus-infected cells, NSP5 and VP2 are colocalized in viroplasms (14). To explore the possible role of the interaction shown above in the colocalization of VP2 and NSP5 in the viroplasms, we used insect cells infected with recombinant baculoviruses. We used amino-terminally deleted VP2 fused to GFP (GFP-
92VP2) instead of VP2, since this fusion protein has the same assembly properties with itself and with VP6 as wild-type VP2 (7). As shown in Fig. 3A, expression of GFP-
92VP2 in Sf9 cells resulted in evenly distributed small fluorescent inclusions. In contrast, coexpression of GFP-
92VP2 and NSP5 resulted in fewer but much larger fluorescent VP2 inclusions (Fig. 3B). These large inclusions contained both VP2 and NSP5 (Fig. 3C1 to C3). Confocal microscopy examination of these insect cells demonstrated that small inclusions present when GFP-
92VP2 was expressed alone clustered together only when NSP5 was coexpressed with GFP-
92VP2. The pattern of fluorescence of GFP-
92VP2 was not modified when it was coexpressed with NSP2 (Fig. 3D). Interestingly, the distribution of GFP-
92VP2 was also modified when VP6, which is known to interact with VP2, was coexpressed (Fig. 3E). The large inclusions characteristic of coexpression of GFP-
92VP2 and NSP5 were not modified when the three proteins VP6, NSP5, and GFP-
92VP2, were coexpressed (Fig. 3F).
![]() View larger version (66K): [in a new window] |
FIG. 3. Distribution of GFP- 92VP2 expressed alone or in combination with other viral proteins. Sf9 cells infected with BacGFP- 92VP2 only (A) or coinfected with BacGFP- 92VP2 and either BacNSP5 (B), BacNSP2 (D), BacVP6 (E), or BacNSP5 and BacVP6 (F) were fixed with paraformaldehyde at 72 h postinfection and observed by confocal fluorescence microscopy. Colocalization of VP2 and NSP5 was verified by immunostaining of insect cells coexpressing GFP-VP2 and NSP5 with the anti-NSP5 MAb 158G37 and a Cy3-labeled donkey anti-mouse immunoglobulin G secondary antibody. Acquisitions of images for each emission wavelength (anti-NSP5, red [C1]; GFP-VP2, green [C2]) were performed sequentially, and the two images were superimposed (C3). Propidium iodide was used for nuclear staining.
|
![]() View larger version (196K): [in a new window] |
FIG. 4. EM of inclusions present in insect cells expressing VP2 or VP2 and NSP5. Sf9 cells were infected either with BacVP2 (A) or with BacVP2 and BacNSP5 (B). Cells were fixed at 72 h postinfection and processed for thin sectioning. Inclusions (Inc) were observed in both cases, but at higher magnifications (insets) it can be observed that the fine structure is different and presents spherical motifs when VP2 is expressed alone. Bars, 300 nm (main panels) and 100 nm (insets)
|
![]() View larger version (35K): [in a new window] |
FIG. 5. Binding of GST-NSP5 to rotavirus particles. (Upper panel) Various types of rotavirus particles (indicated at the top) were analyzed by SDS-PAGE and Coomassie blue staining. They were incubated with a fixed amount of GST-NSP5 bound to glutathione-agarose. (Middle panel) Proteins bound to the solid phase were analyzed by SDS-PAGE and Coomassie blue staining. The protein indicated by an asterisk is a contaminant associated with GST NSP5. (Lower panel) The presence of VP2 bound to GST-NSP5 was confirmed by blotting on polyvinylidene difluoride and immunostaining with anti-VP2 MAb 164E22. Numbers on the left are molecular weights in thousands.
|
![]() View larger version (166K): [in a new window] |
FIG. 6. EM of viral particles after negative staining. Purified DLP (A) and VLP2/6 (B) were treated for 30 min at pH 11 in 20 mM CAPS buffer and then negatively stained and observed at a magnification of x35,000. Bars, 100 nm.
|
92VP2. Proteins present in these bands were analyzed by SDS-PAGE. As shown in Fig. 7 (middle panel), the lower band containing flocculate fluorescent material consisted essentially of GFP-
92VP2 with only trace amounts of VP6 (Fig. 7, middle panel, lane c). The upper band contained GFP-
92VP2 and VP6 in the same proportions as the control (Fig. 7, middle panel, lanes a and b). A small amount of NSP5 was present in both bands obtained when VLP2GFP/6 was incubated with NSP5-containing Sf9 lysate. In contrast, the protein profile of VLP2GFP/6 incubated with Sf9 lysate containing NSP2 was not altered and was identical to the profile obtained before incubation (Fig. 7, middle panel, lane a). EM examination of CsCl bands revealed that the flocculate material corresponded to aggregated VLP essentially devoid of the VP6 layer (Fig. 7, lower right panel), whereas the upper band contained normal VLP (Fig. 7, upper right panel). The same results were obtained when VLP2/6, VLP2
92/6, and VLP1/2/3/6 were substituted for VLP2GFP/6 (data not shown). Incubation of DLP with Sf9 lysate containing NSP5 did not change either their density in CsCl centrifugation or their protein composition (data not shown).
![]() View larger version (62K): [in a new window] |
FIG. 7. Analysis of purified VLP2GFP/6 in a CsCl density gradient after incubation with NSP5. Purified VLP2GFP/6 was incubated with a lysate of Sf9 cells infected with BacNSP5 or BacNSP2 and analyzed by CsCl gradient density centrifugation. (Left panel) A flocculate band can be seen when VLP2GFP/6 is incubated with a lysate from Sf9 cells infected with BacNSP5 but not when it is incubated with a lysate from Sf9 cells infected with BacNSP2. (Middle panel) Protein composition of each band of these gradients after Coomassie blue staining. (Right panels) VLP2/6 and incomplete VLP were observed by EM after staining of bands b (upper panel) and c (lower panel), respectively.
|
|
|
|---|
In rotavirus-infected MA104 cells, most of the NSP5 is hyperphosphorylated, and its interaction with VP2 as demonstrated in these cells is probably due to this form. In this study, we also used nonphosphorylated NSP5 derived from E. coli and phosphorylated (but not hyperphosphorylated) NSP5 derived from insect cells. It was possible to demonstrate the interaction of VP2 with all forms of NSP5. This indicates that the phosphorylation state of NSP5 is not essential for the interaction, but it cannot be excluded that the interaction could be modulated by various degrees of phosphorylation of NSP5. The amino-terminal domain of VP2 is not necessary for the interaction, since a deletion mutant lacking the first 92 amino acids of VP2 interacted with NSP5 as well as wild-type VP2 did. The amino end of VP2 corresponds to the nucleic acid binding domain of VP2. This also suggests that the interaction between the two proteins does not involve nucleic acid.
It has previously been shown that NSP5 expressed alone is evenly distributed into the cytoplasm (1, 27). In this study we demonstrated that VP2 alone is not evenly distributed in insect cells and that coexpression of both proteins resulted in a dramatic change in the size of VP2 inclusions. The increased size of inclusions could simply result from the accumulation of NSP5 and VP2 proteins in the same area. NSP5 is a small oligomeric protein (27) that could link VP2 inclusions in large aggregates. The increased size of VP2 inclusions when NSP5 is present could also be the consequence of a conformational change of VP2 induced by NSP5. This hypothesis is supported by EM observations of an altered morphology of VP2 pseudocores when NSP5 is coexpressed with VP2 in insect cells. A similar increase in the size of viral inclusions has been observed when the core protein of hepatitis C virus is coexpressed with NSP5A in COS-7 cells (13).
In this study, we have shown that NSP5 interacts with VP2 and that VP6 hinders this interaction. The modulation of VP2-NSP5 interaction by VP6 could be due to a strong interaction between VP6 and VP2 that itself could be dependent on the presence of RNA inside viral particles. The interaction between VP2 and VP6 is stronger in DLP than in VLP2/6 as demonstrated by the respective resistances of the two types of particles to high-pH treatment. It can be hypothesized that the binding of NSP5 to core RI that do not yet have their complete set of genomic RNA segments prevents the binding of VP6 that would result in a defective particle containing a partial set of genomic segments, based on the observation that purified DLP did not interact with NSP5. The possibility that some VP6 trimers are absent and allow access to VP2 in VLP2/6 cannot be totally excluded either. The binding of NSP5 to rotavirus cores is reminiscent of the binding of µNS to reovirus cores (6). In reovirus-infected cells, µNS reduces the formation of recoated cores that are transcriptionally active, by the binding of outer capsid proteins µ1 and sigma 3 (which could be considered VP6 and VP7 counterparts, respectively), whereas NSP5, which dislodges VP6 from VLP and binds to transcriptionally inactive cores, could prevent an early start of transcriptase activity of newly formed DLP. It is therefore possible that µNS and NSP5 could both play a role in the delicate switch between transcriptase and replicase activities.
It has already been demonstrated that NSP5 interacts with NSP2 (1, 27). The data presented here are the first evidence of an interaction between NSP5 and a structural protein and the first evidence of an interaction between VP2 and a nonstructural protein. This interaction could be significant in the context of RNA replication and capsid morphogenesis. In a recently proposed model (17, 24), interaction between NSP5 and NSP2 in a complex consisting of VP1, VP3, VP2, NSP2, NSP5, and RNA was considered. Direct interaction between VP2 and NSP5, as demonstrated here, would modify this model and place NSP5 as an intermediate between VP2 and NSP2. Moreover, our results suggested that the competition between VP6 and NSP5 for VP2 could release the NSP2-NSP5 complex from the core RI (26). This could most likely occur at the edge of the viroplasm, where VP6 seems to accumulate (14).
This work was supported by a Programme de Recherche Fondamentale en Microbiologie sur les Maladies Infectieuses et Parasitaires grant (Réseau de Recherche sur les Gastro-entérites à rotavirus) from the Ministère de l'Enseignement de la Recherche et de la Technologie and by a 5th Programme Cadre de Recherche et Développement grant from the Union Européenne (QLRT 1999-00634).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»